Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kensei Yoshikawa is active.

Publication


Featured researches published by Kensei Yoshikawa.


General Pharmacology-the Vascular System | 1993

NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.

Nobuko Futaki; Kensei Yoshikawa; Yumiko Hamasaka; Iwao Arai; Shohei Higuchi; Hiromi Iizuka; Susumu Otomo

1. NS-398 (N-[2-cyclohexyloxy-4-nitrophenyl] methanesulfonamide) is a new non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic effects. 2. The anti-inflammatory potency of NS-398 in rat carrageenin-induced edema was as potent as that of indomethacin and 8 times more potent than diclofenac. In rat adjuvant arthritis, NS-398 showed a therapeutic effect comparable to that seen with loxoprofen but less than that seen with indomethacin and diclofenac. 3. The analgesic potency of NS-398 in rat adjuvant arthritic pain was much the same as that of indomethacin, and was about 3-5 times higher than that of diclofenac and loxoprofen. In the Randall-Selitto method in rats, NS-398 was 2-7 times as potent as loxoprofen, diclofenac and indomethacin. In acetic acid-induced writhing in mice, NS-398 was equipotent to indomethacin and diclofenac. 4. In LPS-induced fever in rats, NS-398 was 1.5-4.5 times as potent as loxoprofen and indomethacin, but less potent than diclofenac. 5. NS-398 produced little gastric ulceration in doses of up to 1000 mg/kg, while reference drugs produced distinct stomach lesions in doses of 10-30 mg/kg. 6. NS-398 inhibited prostaglandin (PG) endoperoxide synthase from sheep seminal vesicle microsomes less potent than that of ibuprofen.


Journal of Chemical Information and Computer Sciences | 2003

Development of a Method for Evaluating Drug-Likeness and Ease of Synthesis Using a Data Set in Which Compounds Are Assigned Scores Based on Chemists' Intuition

Yuji Takaoka; Yutaka Endo; Susumu Yamanobe; Hiroyuki Kakinuma; Taketoshi Okubo; Youichi Shimazaki; Tomomi Ota; Shigeyuki Sumiya; Kensei Yoshikawa

The concept of drug-likeness, an important characteristic for any compound in a screening library, is nevertheless difficult to pin down. Based on our belief that this concept is implicit within the collective experience of working chemists, we devised a data set to capture an intuitive human understanding of both this characteristic and ease of synthesis, a second key characteristic. Five chemists assigned a pair of scores to each of 3980 diverse compounds, with the component scores of each pair corresponding to drug-likeness and ease of synthesis, respectively. Using this data set, we devised binary classifiers with an artificial neural network and a support vector machine. These models were found to efficiently eliminate compounds that are not drug-like and/or hard-to-synthesize derivatives, demonstrating the suitability of these models for use as compound acquisition filters.


Synthetic Communications | 1986

A New Convenient Synthesis of α-Arylpropionic Acid Esters and α-Arylpropionitriles

Takehiro Arnano; Kensei Yoshikawa; Tatsuhiko Sano; Yutaka Ohuchi; Manzo Shiono; Michihiro Ishiguro; Yoshiji Fujita

Abstract Various types of α-arylpropionic acid esters were effectively obtained by the coupling reaction of aryl Grignard reagents and α-bromopropionic acid esters in the presence of nickel catalysts. α-Arylpropionitriles, precursors of α-arylpropionic acids, were also synthesized by the reaction of α-methanesulfonyloxypropionitrile and arylcopper reagents prepared from equimolar amount of arylmagnesium halides and copper(I) bromide.


Bulletin of the Chemical Society of Japan | 1986

Effective synthesis of 2-[4-(3-methyl-2-butenyl)phenyl]propionic acid via hydromagnesation reaction with nickel or titanium catalysts

Takehiro Amano; Tomomi Ota; Kensei Yoshikawa; Tatsuhiko Sano; Yutaka Ohuchi; Fumie Sato; Manzo Shiono; Yoshiji Fujita


Chemical & Pharmaceutical Bulletin | 1986

Synthesis and antiinflammatory activity of alkenylphenylpropionic acids.

Takehiro Amano; Kensei Yoshikawa; Toshihisa Ogawa; Tatsuhiko Sano; Yutaka Ohuchi; Tohru Tanami; Tomomi Ota; Katsuo Hatayama; Shohei Higuchi; Fusao Amanuma; Kaoru Sota


Archive | 1982

Process for producing alpha-arylalkanoic acid esters

Takehiro Amano; Kensei Yoshikawa; Tatsuhiko Sano; Yutaka Ohuchi; Michihiro Ishiguro; Manzo Shiono; Yoshiji Fujita; Takashi Nishida


Archive | 1992

5-aminosulfonanilide compounds

Kensei Yoshikawa; Shiuji Saito; Yohichi Shimazaki; Mariko Kashiwa; Katsuo Hatayama


Archive | 1982

Process for producing α-arylalkanoic acid ester

Takehiro Amano; Kensei Yoshikawa; Tatsuhiko Sano; Yutaka Ohuchi; Michihiro Ishiguro; Manzo Shiono; Yoshiji Fujita; Takashi Nishida


Archive | 1993

5-amino-2-phenoxysulfonanilide compound

Kensei Yoshikawa; Shuji Saito; Yohichi Shimazaki; Mariko Kashiwa; Katsuo Hatayama


Archive | 1984

Novel styrene derivatives of the general formula

Katsuo Hatayama; Kensei Yoshikawa; Tatsuhiko Sano; Yutaka Ohuchi; Tomomi Ota; Kazuto Sekiuchi; Kaoru Sota

Collaboration


Dive into the Kensei Yoshikawa's collaboration.

Top Co-Authors

Avatar

Katsuo Hatayama

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Tatsuhiko Sano

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Yutaka Ohuchi

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Manzo Shiono

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Mariko Kashiwa

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Shiuji Saito

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Takehiro Amano

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Yoshiji Fujita

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge